Cite
HARVARD Citation
Sorosina, M. et al. (2018). Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. European journal of neurology. pp. 934-e70. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sorosina, M. et al. (2018). Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. European journal of neurology. pp. 934-e70. [Online].